Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Juewen Xu"'
Autor:
Xixi Li, Shunyao Zhu, Ping Yin, Shuangshuang Zhang, Juewen Xu, Qin Zhang, Senlin Shi, Ting Zhang
Publikováno v:
Drug Delivery, Vol 28, Iss 1, Pp 1849-1860 (2021)
Melanoma is one of the most common malignant tumors. The anti-PD-1 antibody is used for the treatment of metastatic melanoma. Treatment success is only 35–40% and a range of immune-related adverse reactions can occur. Combination of anti-PD1 antibo
Externí odkaz:
https://doaj.org/article/3527c939b8664edcafbb6fe359451f06
Autor:
Yinfang Lai, Liping Hua, Jiali Yang, Juewen Xu, Junduo Chen, Shuangshuang Zhang, Shunyao Zhu, Jingjing Li, Senlin Shi
Publikováno v:
Molecules, Vol 28, Iss 2, p 635 (2023)
Objective: To study the extraction process of agarwood active ingredients (AA) and investigate the safety and effectiveness of AA in the treatment of insomnia rats by nasal administration. Method: A β-cyclodextrin (β-CD) inclusion compound (a-β-CD
Externí odkaz:
https://doaj.org/article/5dcde47b5d3a4731adcaebd6610bf9d4
Publikováno v:
Pharmaceutics, Vol 14, Iss 5, p 923 (2022)
As a biopharmaceutics classification system (BCS) class IV drug, breviscapine (Bre) has low solubility in water, poor chemical stability, a short biological half-life and rapid removal from plasma. This paper prepared a Bre nanosuspension (Bre-NS) by
Externí odkaz:
https://doaj.org/article/cfa65e16425c4fb9a9d1ad920bb4f8b9
Publikováno v:
British Journal of Nutrition. :1-13
Cuscuta chinensis Lam. is a traditional medicinal herb used to treat female sterility and male reproductive system disorders. However, the anti-lung cancer properties of Cuscuta chinensis Lam. and possible molecular mechanisms have yet to be explored
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3bf176f0d137e72872a7df1c93a41756
https://doi.org/10.1017/s0007114522003865
https://doi.org/10.1017/s0007114522003865
Autor:
Shuangshuang Zhang, Qin Zhang, Ting Zhang, Shunyao Zhu, Ping Yin, Senlin Shi, Juewen Xu, Xixi Li
Publikováno v:
Drug Delivery, Vol 28, Iss 1, Pp 1849-1860 (2021)
Drug Delivery
article-version (VoR) Version of Record
Drug Delivery
article-version (VoR) Version of Record
Melanoma is one of the most common malignant tumors. The anti-PD-1 antibody is used for the treatment of metastatic melanoma. Treatment success is only 35–40% and a range of immune-related adverse reactions can occur. Combination of anti-PD1 antibo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88dac7712d309fe4e60f8ab45e0c2abb
https://doi.org/10.1080/10717544.2021.1971797
https://doi.org/10.1080/10717544.2021.1971797